Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Biomarkers and Pharmaceutical Care
Project funded by own resources
Project title Biomarkers and Pharmaceutical Care
Principal Investigator(s) Hersberger, Kurt
Arnet, Isabelle
Co-Investigator(s) Tsakiris, Dimitrios
Walter, Philipp
Organisation / Research unit Departement Pharmazeutische Wissenschaften / Pharmaceutical Care (Hersberger)
Project start 01.12.2008
Probable end 31.12.2012
Status Completed
Abstract

Drug resistance is a debatable phenomenon in many fields of drug therapy. Current definitions of drug resistance are inconsistent and involve various contributing factors. It is our strong belief that electronic compliance monitoring of all solid oral drugs and biomarker measurements form the cornerstones of any study investigating drug resistance.

Successful therapy with inhibitors of blood platelet function is crucial in patients with ischemic vascular disease to prevent fatal or nonfatal clinical events (1996). A proportion of 5.8 – 25% of patients with a prescription for clopidogrel experience therapy failure in terms of inadequately diminished in vitro platelet function (Gladding, Webster et al. 2008), Aspirin resistance in terms of clinical therapy failure have been reported in 10-20% (Angiolillo 2009). A lack of reduction of in vitro platelet aggregation is associated with clinical therapy failure (Angiolillo 2009).

We developped a study design to investigate antiplatelet resistance to aspirin and clopidogrel, which can be seen as a template when investigating drug resistance in general.

Our project aims at:

  • discovering the role of noncompliance to the phenomenon of anti-platelet resistance (study A),
  • identifying factors associated with nonresponse (study B)
  • studying the relationship between compliance and platelet aggregation (study C).

ClinicalTrials.gov Nr. NCT01039480

Keywords Drug resistance, compliance, electronic monitoring, clopidogerl
Financed by University funds

Published results ()

  ID Autor(en) Titel ISSN / ISBN Erschienen in Art der Publikation
1023319  Walter, P.; Tsakiris, D.; Romanens, M.; Kort, W.; Arnet, I.; Hersberger, K. E.  Fundamental progress in investigating drug resistance with electronic multidrug compliance monitoring (e-MCM)    Journal of Patient Compliance  Publication: JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift) 

Documents ()

  Document
 
   

MCSS v5.8 PRO. 0.364 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/06/2024